Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Feasibility Study to Evaluate the Safety and Performance of Low-Energy Therapy in Patients With Atrial Fibrillation Energy Therapy in Patients With Atrial Fibrillation

NCT04206917 is registered in ClinicalTrials.gov with Cardialen, Inc. as lead sponsor.

NCT NCT04206917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04206917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Feasibility Study to Evaluate the Safety and Performance of Low-Energy Therapy in Patients With Atrial Fibrillation Energy Therapy in Patients With Atrial Fibrillation
Lead sponsor
Cardialen, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
March 19, 2020
Completion date
June 21, 2022
Enrollment
30 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, atrial fibrillation, paroxysmal, atrial fibrillation, persistent